Catalyst Pharmaceutical Partners (CPRX)

[finesand]

Bernie Sanders bashes $CPRX for ODD Economics again

It is funny to watch CPRX being bashed by this Bernie Sanders for the ODD pricing model. A Senator yelling around trying to kill the economics of rare disease drug development.
Nasty and harming all potential patients.

CPRX's reply earlier was https://ir.catalystpharma.com/static-files/9d93296c-de07-4691-9aa6-2ed9478bffc0

Jacobus only addressed 200 of the 3000 patients and their unstable drug variation has a short shelf life and must be cooled at all times. CPRX's variation can be stored at room temperature.

This was Sanders's second weirdo approach.

Company released a news item to support Rare Disease Day 2019, surely for awareness. https://finance.yahoo.com/news/catalyst-pharmaceuticals-announces-support-rare-130300799.html

ODD drug development costs money & time, regardless weather you purchase the molecule/compound or 'find' it yourself. Subsequent clinical trials consume quite some money to please exactly what the FDA requires: Compliance.

Removing ODD regulations would open a wormhole of lawsuits and threaten the economics of rare disease drug development.
It would threaten the very people benefiting from these rules: The patients. No pharma would be able to develop these drugs otherwise.

(Compilation of thoughts from SoS and myself)